arrow
Y

Yaser Jenab

Tehran University of Medical Sciences
H指数:18
被引数:956

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Distinct Predictors of Post-thrombotic Symptoms, Signs, and Ulcers after a First Episode Deep Vein Thrombosis: A RIETE Registry Study

首次深静脉血栓形成后血栓后症状、体征和溃疡的不同预测因子:一项RIETE注册研究

2026-06-080
PRE
Adjunctive Eptifibatide Administration in ACS Patients Undergoing Percutaneous Coronary Intervention: A Randomized Comparison of Bolus-only Versus Standard Therapy

在经皮冠状动脉介入治疗的ACS患者中辅助给予依替巴肽:比较单次推注与标准疗法的随机对照研究

2026-05-010
OAAI
Efficacy and safety of colchicine in patients with acute coronary syndrome: a systematic review and meta-analysis of randomized controlled trials

秋水仙碱在急性冠状动脉综合征患者中的有效性和安全性:一项系统评价和随机对照试验的荟萃分析

2025-09-290
OAAI
Trends in Transcatheter Versus Surgical Aortic Valve Replacement Outcomes in Patients With Low-Surgical Risk: A Systematic Review and Meta-Analysis of Randomized Trials

低手术风险患者经导管与外科主动脉瓣置换术结局的趋势: 随机试验的系统评价和荟萃分析

2024-10-180
PRE
Immunomodulatory potential of human clonal mesenchymal stem cells and their extracellular vesicle subpopulations in an inflammatory-mediated diabetic Rhesus monkey model

人克隆间充质干细胞及其胞外囊泡亚群在炎症介导的糖尿病恒河猴模型中的免疫调节潜能

2023-09-014
PRE
Evaluating the role of intravenous pentoxifylline administration on primary percutaneous coronary intervention success rate in patients with ST-elevation myocardial infarction (PENTOS-PCI)
2023-03-010
OAAI
Effects of opium use on one-year major adverse cardiovascular events (MACE) in the patients with ST-segment elevation MI undergoing primary PCI: a propensity score matched-machine learning based study

使用鸦片对接受直接PCI的ST段抬高MI患者一年主要不良心血管事件 (MACE) 的影响: 一项基于倾向评分匹配机器学习的研究

2023-01-195
OAAI
Catheter-Directed Thrombolysis vs Anticoagulation in Patients With Acute Intermediate-High-risk Pulmonary Embolism The CANARY Randomized Clinical Trial
2022-12-0151
OA
The impact of a dedicated coronavirus disease 2019 primary angioplasty protocol on time components related to ST-segment elevation myocardial infarction management in a 24/7 primary percutaneous coronary intervention-capable hospital
2020-12-239
OA